Heart left artery
Searched over 200M research papers
Summary
4 papers analyzed
These studies suggest that while CABG is the standard treatment for left main coronary artery disease, PCI is a feasible alternative for selected patients, and surgical correction is necessary for anomalous origin of the left coronary artery from the pulmonary artery.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Management and Treatment of Left Main Coronary Artery Disease
Introduction to Left Main Coronary Artery Disease (LMCAD)
Left main coronary artery disease (LMCAD) is a critical condition due to the large myocardial mass at risk, leading to high morbidity and mortality rates. Effective management of LMCAD is essential to improve patient outcomes and survival rates.
Revascularization Strategies: CABG vs. PCI
Coronary Artery Bypass Grafting (CABG)
Coronary artery bypass grafting (CABG) has traditionally been the standard treatment for LMCAD. This surgical procedure is recommended for most patients with significant left main stenosis to improve survival rates. CABG is particularly favored in patients with complex coronary anatomy and those who are at high risk for percutaneous coronary intervention (PCI).
Percutaneous Coronary Intervention (PCI)
Recent advancements in PCI techniques, including the use of intracoronary imaging and functional assessment, have made PCI a viable alternative to CABG for selected patients. PCI is especially considered for patients with low to intermediate anatomic complexity and those with comorbidities or contraindications to CABG . Studies have shown that PCI and CABG have comparable clinical outcomes, with similar rates of mortality and serious composite outcomes. However, PCI is associated with a higher rate of repeat revascularization, while CABG has a higher rate of stroke.
Secular Trends in LMCAD Treatment and Outcomes
Over time, the characteristics, treatment approaches, and clinical outcomes for patients with unprotected LMCAD have evolved. Data from the IRIS-MAIN registry indicate that both PCI and CABG are reasonable options, with guideline recommendations supporting PCI as an alternative to CABG in appropriate patients. This evolution reflects the continuous improvements in PCI techniques and the growing body of evidence supporting its efficacy.
Anomalous Origin of the Left Coronary Artery
Anomalous origin of the left coronary artery from the pulmonary artery is a rare congenital defect that is almost universally fatal if untreated. The physiological defect involves abnormal blood flow from the pulmonary artery to the myocardium. Surgical treatment typically involves ligation of the aberrant artery to prevent irreversible myocardial damage.
Inter-Observer Variation in Radiotherapy for Breast Cancer
In the context of radiotherapy for breast cancer, accurate delineation of the heart and left anterior descending coronary artery (LADCA) is crucial to minimize radiation exposure. A study found significant inter-observer variation in the delineation of these structures, which impacts the estimated doses received. The use of common guidelines reduced spatial variation for the heart but not for the LADCA, highlighting the need for improved standardization in radiotherapy planning.
Conclusion
The management of left main coronary artery disease involves a careful consideration of revascularization strategies, with CABG remaining the standard treatment and PCI emerging as a viable alternative for selected patients. Continuous advancements in PCI techniques and a better understanding of patient characteristics and outcomes are shaping the future of LMCAD treatment. Additionally, addressing inter-observer variation in radiotherapy planning is essential to optimize treatment outcomes for patients with breast cancer involving the heart and LADCA.
Sources and full results
Most relevant research papers on this topic
